Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Procter & Gamble Hygiene and Health Care Ltd

PGHH
NSE
10,370.50
1.76%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Procter & Gamble Hygiene and Health Care Ltd

PGHH
NSE
10,370.50
1.76%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
33,663Cr
Close
Close Price
10,370.50
Industry
Industry
FMCG - Personal Care
PE
Price To Earnings
39.17
PS
Price To Sales
7.76
Revenue
Revenue
4,341Cr
Rev Gr TTM
Revenue Growth TTM
0.56%
PAT Gr TTM
PAT Growth TTM
20.05%
Peer Comparison
How does PGHH stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
PGHH
VS

Quarterly Results

Upcoming Results on
28 May 2026
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
8838531,1381,1331,0029321,1351,2489929371,1501,262
Growth YoY
Revenue Growth YoY%
-9.39.88.9-0.313.59.3-0.310.1-1.10.61.31.1
Expenses
ExpensesCr
734638853824745813845877782671865860
Operating Profit
Operating ProfitCr
149215285310257118290371210266285402
OPM
OPM%
16.925.225.027.325.712.725.629.721.128.424.831.8
Other Income
Other IncomeCr
141016161479101981012
Interest Expense
Interest ExpenseCr
4323220276043
Depreciation
DepreciationCr
1515141415131210109910
PBT
PBTCr
146207284309234112285364213265282402
Tax
TaxCr
-1955748080317396577372101
PAT
PATCr
16515121122915481212269156192210301
Growth YoY
PAT Growth YoY%
60.5255.436.510.3-6.5-46.40.617.31.1136.9-1.012.2
NPM
NPM%
18.717.718.520.215.48.718.721.515.720.518.323.9
EPS
EPS
50.846.664.970.547.625.065.382.748.159.264.792.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearJun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025TTM
Revenue
RevenueCr
2,3342,2752,3202,4552,9473,0023,5743,9013,9184,2063,3744,341
Growth
Revenue Growth%
-2.52.05.820.01.919.19.10.47.328.6
Expenses
ExpensesCr
1,8491,6701,6561,8402,3382,3982,6903,0713,0493,2352,5033,178
Operating Profit
Operating ProfitCr
4846066656156096048848308699708711,162
OPM
OPM%
20.826.628.625.120.720.124.721.322.223.125.826.8
Other Income
Other IncomeCr
758877245344392441523749
Interest Expense
Interest ExpenseCr
661055661111271412
Depreciation
DepreciationCr
535260525048485358573238
PBT
PBTCr
5016366725826075948707908399398621,161
Tax
TaxCr
155213239207188161218214161264226302
PAT
PATCr
346423433375419433652576678675637859
Growth
PAT Growth%
22.12.4-13.411.93.350.5-11.717.8-0.535.0
NPM
NPM%
14.818.618.615.314.214.418.214.817.316.118.919.8
EPS
EPS
106.6130.2133.3115.4129.1133.4200.8177.4208.9207.9196.1264.8

Balance Sheet

Standalone
Numbers
Percentage
Financial YearJun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
323232323232323232323232
Reserves
ReservesCr
1,1961,6194947738771,125682705914742705899
Current Liabilities
Current LiabilitiesCr
7165115825716425958358601,0859819011,086
Non Current Liabilities
Non Current LiabilitiesCr
34524966758385106103117116
Total Liabilities
Total LiabilitiesCr
1,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133
Current Assets
Current AssetsCr
1,3571,6326038151,0901,3281,1171,1351,4961,2001,0911,489
Non Current Assets
Non Current AssetsCr
591535557611527500515547642659664645
Total Assets
Total AssetsCr
1,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133

Cash Flow

Standalone
Financial YearJun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
426352445415413474863573826470593
Investing Cash Flow
Investing Cash FlowCr
28221149-1934757-27-101-34
Financing Cash Flow
Financing Cash FlowCr
-105-122-1,559-106-314-190-1,106-569-477-861-666
Net Cash Flow
Net Cash FlowCr
349452-964290134358-236-23339-390-107
Free Cash Flow
Free Cash FlowCr
427300401377410423832523781427539
CFO To PAT
CFO To PAT%
123.083.4102.9110.998.5109.4132.499.5121.869.693.2
CFO To EBITDA
CFO To EBITDA%
87.858.267.067.567.878.597.669.195.148.468.1

Ratios

Standalone
Financial YearJun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
21,98720,38126,11932,14134,75132,96443,26843,50946,43353,95144,158
Price To Earnings
Price To Earnings
63.548.260.485.882.976.166.475.668.579.952.0
Price To Sales
Price To Sales
9.49.011.313.111.811.012.111.211.812.813.1
Price To Book
Price To Book
17.912.349.639.938.228.560.659.049.169.659.9
EV To EBITDA
EV To EBITDA
44.131.939.151.656.153.148.251.752.355.050.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.561.160.661.458.063.167.660.057.561.662.8
OPM
OPM%
20.826.628.625.120.720.124.721.322.223.125.8
NPM
NPM%
14.818.618.615.314.214.418.214.817.316.118.9
ROCE
ROCE%
41.238.9129.772.967.451.8122.0107.989.6124.2118.5
ROE
ROE%
28.225.682.346.546.137.491.378.171.787.186.4
ROA
ROA%
17.819.537.326.325.923.739.934.231.736.336.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Procter & Gamble Hygiene and Health Care Limited (PGHH) is a leading Indian consumer goods company and a subsidiary of The Procter & Gamble Company, USA. It operates in two high-growth, performance-driven categories: **Feminine Hygiene** and **Personal Healthcare**, with market leadership in both segments. The company leverages global innovation, deep consumer insights, and digital-first strategies to deliver superior products that meet evolving consumer needs across urban and rural India. PGHH’s brand portfolio is anchored by **Whisper** in feminine care and **Vicks** in healthcare—both trusted household names. The company continues to grow through product innovation, digital transformation, and social impact initiatives that blend commercial success with purpose-driven engagement. --- ### **Core Business Segments & Market Position** #### **1. Feminine Hygiene (70% of Revenue)** - **Market Leadership**: PGHH holds **nearly 50% market share** in India’s feminine care category, which has grown **100-fold over the past 30 years**—from Rs 34 crores to over Rs 3,400 crores. - **Penetration Gaps**: Urban penetration is ~60%, rural <40%, with significant growth potential ahead. Per capita usage remains below one-sixth of China’s, indicating a large untapped opportunity. - **Key Brands**: - **Whisper Ultra**: Features **Curvewear Technology** (world-first raised center for seamless fit), **cushion core**, and **100% leak protection**. - **Whisper Choice**: Upgraded with softer, **cotton-like top sheet** for enhanced comfort; now includes **Nights variants** and **Ultra XL** for heavy flow. - **Whisper FlexFoam**: Uses patented foam technology for flexibility and comfort. - **Whisper Period Panties**: Super-premium offering with **360-degree leakage protection**, high absorption, breathable waistband, and now expanded **size-inclusive range**. #### **2. Personal Healthcare (30% of Revenue)** - **Market Share**: Over **50% in cough & cold** category; dominant in throat drops, rubs, inhalers, and sleep aids. - **Revenue Contribution**: Healthcare is the fastest-growing segment in e-commerce, with **ZzzQuil as the #1 bestseller** in sleep supplements on online platforms. - **Key Brands**: - **Vicks VapoRub**: Reformulated with a **New Powerful Scent** for enhanced nighttime relief in children; promoted via the **‘V-Banao, Vicks Lagao’** campaign teaching optimal 'V' application. - **Vicks Cough Drops Double Power**: Larger size, higher ayurvedic content, longer-lasting relief. - **Vicks Cough Syrup**: Launched in 2025 as a **premium herbal-Ayurvedic hybrid**, targeting demand for natural remedies; available via e-commerce and quick commerce. - **Vicks Roll-On**: Portable, fast-acting (within 2 minutes) relief for headaches using menthol and camphor; complements cold symptom treatment. - **Vicks Inhaler**: Natural, on-the-go relief from nasal congestion. - **ZzzQuil**: Nutritional sleep aid in gummy and liquid form; growing at **double-digit rates on e-commerce**; partnered with **World Sleep Society** for awareness. --- ### **Recent Innovations (2024–2025)** PGHH has launched category-defining products and reimagined existing ones with a **consumer-first innovation strategy**: - **Whisper Ultra & Bindazzz Nights**: Refreshed with **Gen-Z-friendly, de-cluttered packaging** and promoted through influencer-led “edutainment” content under the **‘Real Periods Real Solution’** campaign. - **Whisper Ultra XL for Heavy Flow**: Introduces **cushion core technology** and soft top layer for comfort and full leak protection. - **Vicks VapoRub Steam Pods**: First globally launched steam inhalation capsules from P&G; modern format for targeted relief. - **Vicks Headache Roll-on**: Non-greasy, portable relief using high-strength Ayurvedic ingredients. - **New Sub-Categories**: Creation of premium segments like **Whisper Period Panties** and **ZzzQuil gummies**, establishing new consumer expectations. --- ### **Marketing & Consumer Engagement** #### **Digital & Influencer Strategy** - Targeted **Gen-Z** consumers via **influencer partnerships** and **e-commerce-first** campaigns. - Ran India’s **largest menstrual education program**, reaching **over 10 crore girls and mothers** across schools. - **#KeepGirlsInSchool** campaign in its **5th edition (2024–25)** to combat stigma, advocate for mandatory education, and improve school retention. - Award-winning **‘The Missing Chapter’** campaign (Cannes Lions 2022 Grand Prix) continues to drive social impact. #### **Quick Commerce Partnerships** - Co-created campaigns with **Zepto** for **10-minute delivery** of Whisper Period Panties, combining **urgency, visibility, and education**. - Expanded access via **quick commerce, e-pharmacies, and e-commerce platforms**. --- ### **Supply Chain & Technology Leadership** - **Supply 3.0 Initiative**: End-to-end optimization using **AI and machine learning**. Achieved: - **60% reduction in supply chain touchpoints** - **35% faster speed to market** - **6 million km reduction in logistics** - Lower carbon footprint and improved resilience. - **AI-Driven Retail Execution**: - In-house algorithms optimize **store-level product assortments** and **shelf visibility** across physical and dark stores. - Enhanced **distributor ordering accuracy** and **inventory turnover**. - **AI in Manufacturing**: Uses **image recognition for automated quality checks**, improving speed and consistency. --- ### **Growth Strategy & Performance** PGHH follows a **Five-Pillar Integrated Growth Strategy**: 1. **Product Superiority**: Across performance, packaging, communication, retail execution, and value. 2. **Consumer-First Innovation**: Addressing "jobs to be done" through continuous R&D. 3. **Digital Acceleration**: E-commerce contributes **double-digit % of total revenue**; ZzzQuil and Whisper Nights see exponential online growth. 4. **Productivity as a Growth Lever**: Saved **over Rs 105 crore** in FY 2023 through systemic productivity initiatives. 5. **Social Purpose Integration**: Combines brand building with education to expand category demand. - **Whisper Nights**: Grew **150x YoY**, driven by bundling and education on night-time protection. - **ZzzQuil**: Top-selling sleep supplement on e-commerce (P3M); available in Tier I and Tier II cities. --- ### **Leadership & Governance** - **Mr. Iyer**, Managing Partner – Rational Equity Partners LLP, brings **40+ years of leadership experience**, including as **President & CEO of Walmart India**. Holds CA and CS qualifications and a Commerce degree from Sydenham College, Mumbai. --- ### **Competitive Landscape** - Organized D2C and unorganized players hold **<10% market share combined** in feminine hygiene. - PGHH maintains leadership through **brand trust, innovation, and broad distribution**. - Despite challenges like **consumer down-trading and inflation**, the company has grown market share via **superior execution and value-tier segmentation** (Rs 4–7 and >Rs 7 per pad).